U.S. flag

An official website of the United States government

NM_021870.3(FGG):c.666+23T>A AND Congenital afibrinogenemia

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 27, 2019
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000984549.1

Allele description [Variation Report for NM_021870.3(FGG):c.666+23T>A]

NM_021870.3(FGG):c.666+23T>A

Gene:
FGG:fibrinogen gamma chain [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
4q32.1
Genomic location:
Preferred name:
NM_021870.3(FGG):c.666+23T>A
HGVS:
  • NC_000004.12:g.154609607A>T
  • NG_008834.1:g.8144T>A
  • NM_000509.6:c.666+23T>A
  • NM_021870.3:c.666+23T>AMANE SELECT
  • LRG_585t1:c.666+23T>A
  • LRG_585t2:c.666+23T>A
  • ENST00000336098.8:c.666+23T>A
  • LRG_585:g.8144T>A
  • NC_000004.11:g.155530759A>T
Links:
dbSNP: rs1578810856
NCBI 1000 Genomes Browser:
rs1578810856
Molecular consequence:
  • NM_000509.6:c.666+23T>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_021870.3:c.666+23T>A - intron variant - [Sequence Ontology: SO:0001627]
Functional consequence:
sequence_variant_affecting_splicing [Sequence Ontology: SO:1000071]

Condition(s)

Name:
Congenital afibrinogenemia
Identifiers:
MONDO: MONDO:0008737; MedGen: C2584774; Orphanet: 335; OMIM: 202400

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001029718Biochemistry Laboratory, Bechir Hamza Children's Hospital
no assertion criteria provided
Pathogenic
(Nov 27, 2019)
germlineresearch

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
African germlineyes1not providednot providednot providednot providedresearch

Details of each submission

From Biochemistry Laboratory, Bechir Hamza Children's Hospital, SCV001029718.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1African1not providednot providedresearchnot provided

Description

The patient was a 50-year-old man from a consanguineous marriage. He was diagnosed with hypofibrinogenemia when he was 40 years old, following investigations of an unusual bleeding after dental care. He developed an acute myocardial infarction two years later, managed without revascularization but introduction of atenolol, aspirin, atorvastatin, and captopril. The clinical course was finally uneventful. The patient had neither cardiovascular risk factors nor family history of bleeding disorder. All coagulation-based tests were severely affected, including an infinitely prolonged activated partial thromboplastin time, a severely reduced prothrombin activity and an infinitely prolonged thrombin time. Further investigations showed that all plasma-clotting factors were in the normal range except fibrinogen, which was extremely reduced (0.31g/L) when measured by the Clauss method and (0.36g/L) when assayed by the turbidimetric latex immunoassay, suggesting severe hypofibrinogenemia

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Sep 24, 2022